These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 34565538

  • 21. Quality of life, psychosocial strains and coping in parents of children with haemophilia.
    Wiedebusch S, Pollmann H, Siegmund B, Muthny FA.
    Haemophilia; 2008 Sep; 14(5):1014-22. PubMed ID: 18624702
    [Abstract] [Full Text] [Related]

  • 22. Major bleeding disorders: diagnosis, classification, management and recent developments in haemophilia.
    Bhatnagar N, Hall GW.
    Arch Dis Child; 2018 May; 103(5):509-513. PubMed ID: 29175823
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.
    McCary I, Guelcher C, Kuhn J, Butler R, Massey G, Guerrera MF, Ballester L, Raffini L.
    Haemophilia; 2020 Jul; 26(4):631-636. PubMed ID: 32311809
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Home treatment in hemophilia].
    Pabinger I, Niessner H, Korninger C, Nowotny C, Stain M, Kyrle PA, Lechner K.
    Wien Klin Wochenschr; 1987 Nov 20; 99(22):773-7. PubMed ID: 3124354
    [Abstract] [Full Text] [Related]

  • 28. Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals.
    Buckley B, Dreyfus J, Prasad M, Gayle J, Kendter J, Hall E.
    Haemophilia; 2018 May 20; 24(3):e93-e102. PubMed ID: 29577531
    [Abstract] [Full Text] [Related]

  • 29. Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A.
    Le Quellec S.
    Drug Des Devel Ther; 2020 May 20; 14():469-481. PubMed ID: 32099331
    [Abstract] [Full Text] [Related]

  • 30. Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors.
    Cortesi PA, Castaman G, Trifirò G, Creazzola SS, Improta G, Mazzaglia G, Molinari AC, Mantovani LG.
    Thromb Haemost; 2020 Feb 20; 120(2):216-228. PubMed ID: 31887777
    [Abstract] [Full Text] [Related]

  • 31. Functional limitations in Romanian children with haemophilia: further testing of psychometric properties of the Paediatric Haemophilia Activities List.
    Groen W, van der Net J, Lacatusu AM, Serban M, Helders PJ, Fischer K.
    Haemophilia; 2013 May 20; 19(3):e116-25. PubMed ID: 23374095
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors.
    Kempton C, Trask P, Parnes A, Niggli M, Campinha-Bacote A, U Callaghan M, O'Connell N, Paz-Priel I, Mahlangu JN.
    Haemophilia; 2021 Mar 20; 27(2):221-228. PubMed ID: 33506955
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Parents of children with haemophilia--a transforming experience.
    Beeton K, Neal D, Watson T, Lee CA.
    Haemophilia; 2007 Sep 20; 13(5):570-9. PubMed ID: 17880446
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. How I treat children with haemophilia and inhibitors.
    Young G.
    Br J Haematol; 2019 Aug 20; 186(3):400-408. PubMed ID: 31069799
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.